Kyla Susann Walker, LME, RMA | |
3500 188th St Sw Ste 670, Lynnwood, WA 98037-4782 | |
(206) 209-0988 | |
(206) 209-0992 |
Full Name | Kyla Susann Walker |
---|---|
Gender | Female |
Speciality | Plastic Surgery |
Location | 3500 188th St Sw Ste 670, Lynnwood, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225631609 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 113642 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kyla Susann Walker, LME, RMA 3500 188th St Sw Ste 670, Lynnwood, WA 98037-4782 Ph: (206) 209-0988 | Kyla Susann Walker, LME, RMA 3500 188th St Sw Ste 670, Lynnwood, WA 98037-4782 Ph: (206) 209-0988 |
News Archive
At first glance, Down syndrome and Alzheimer's disease, two severe brain abnormalities, may seem to have little in common. Down syndrome is a hereditary disease, the source of which has long been recognized-a triplication of chromosome 21.
A report by a presidential advisory panel urges the federal government to be more aggressive in facilitating the adoption of universal standards for sharing electronic health information and maintaining patient privacy.
Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application for Losartan Potassium Tablets USP, 25mg, 50mg and 100mg as well as Losartan Potassium and Hydrochlorothiazide Tablets, 50mg/12.5mg and 100mg/25mg by the U.S. Food and Drug Administration. Both products are available for immediate shipment to wholesalers and pharmacies nationwide.
A cohesive team environment, assessing one's own performance rather than comparing with others, and involvement in enjoyably challenging practices are the main conditions needed for children to have a positive developmental experience playing team sports.
Initial results from an ongoing clinical trial, the first designed to examine the utility of whole-genome sequencing for triple negative breast cancer, were reported today during the CRTC-AACR San Antonio Breast Cancer Symposium.
› Verified 7 days ago